Global Obesity Treatment Market- Industry Analysis and forecast 2019 – 2027: By Surgery, Drugs, End Use, and Region.

Global Obesity Treatment Market size was valued nearly US$ 7.12 Bn. in 2019 and the total revenue is expected to grow at XX% from 2019 to 2027, reaching nearly US$ XX Bn.   Global Obesity Treatment Market To know about the Research Methodology :- Request Free Sample Report The report study has analyzed the revenue impact of COVID -19 pandemic on the sales revenue of market leaders, market followers, and market disrupters in the report, and the same is reflected in our analysis. Obesity is a disorder characterized by an extreme amount of body fat. The most commonly used principles to assess the existence and the severity of obesity are waist circumference, body mass index, waist-to-height ratio, and the occurrence of the health conditions caused or degenerated by obesity. Global obesity has increased more than double in the last four decades. Obesity is the second foremost preventable causes of death globally. Treatment of obesity mostly incorporates two-step processes that are management and assessment. Obesity assessment contains the determination of the obesity level and obesity management includes overall maintenance of body weight including the organized weight loss programs. The MMR report contains a detailed study of factors that will drive and restrain the growth of the obesity treatment market. Such as, the global market for obesity treatment is driven by a number of factors like technological advancements in the medical industry, easy obtainability of weight management treatments commercially and many government initiatives concerning overweight issues. As per the world health organization (WHO), about 13% of the global population is categorized as ‘obese’. Weights regain after obesity treatments and high prices are the major hindrances faced by the obesity treatment market globally. North America obesity treatment market was valued US$ XX Mn. in 2019 and is expected to reach a value of US$ XX Mn. by 2027, with a CAGR of XX.60% during the forecast period. The USA holds major share thanks to the growing obese population influenced by the changing lifestyles in various economies and the increasing spending on R&D and healthcare industry. Global Obesity Treatment Market1 Europe holds the second largest share in the obesity treatment market and it is expected to grow at a CAGR of XX.34 % during 2019-2027. Europe aids from the availability of research funds, mounting obese population, and growing adoption of bariatric surgeries. The MMR report will also provide an accurate prediction of the contribution of the various segments to the growth of the obesity treatment market size. By surgery, the endoscopic procedures segment expected to grow at the highest XX.35% CAGR during the forecast period. This is because of the falling incidences of post-operative infections that stem from non-invasive & invasive procedures. Major players in the obesity treatment market have taken several strategic measures, such as facility expansions and partnerships. Such as, in 2019, Boehringer Ingelheim Company has cooperated with Gubra group to develop new poly-agonist peptides for the obesity treatment. This will be their second cooperation, which will combine Gubra’s know-how in the synthesis, design, in vivo testing of therapeutic peptides and pharmaceutical description with Boehringer Ingelheim Company in R&D of advanced medicines for cardio metabolic diseases. The objective of the report is to present a comprehensive analysis of the Global Obesity Treatment Market including all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that includes market leaders, followers, and new entrants. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors of the market has been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers. The report also helps in understanding Global Obesity Treatment Market dynamics, structure by analyzing the market segments and projects the Global Obesity Treatment Market size. Clear representation of competitive analysis of key players by Application, price, financial position, Product portfolio, growth strategies, and regional presence in the Global Obesity Treatment Market make the report investor’s guide.

Scope of the Global Obesity Treatment Market: Inquire before buying

Global Obesity Treatment Market, By Surgery

• Adjusting gastric Banding • Roux-en-Y Gastric Bypass • Sleeve gastrectomy • Biliopancreatic diversion with Duodenal Switch • Endoscopic Procedures

Global Obesity Treatment Market, By Drugs

• Appetite suppressants • Combination drugs • Malabsorption • Satiety drugs

Global Obesity Treatment Market, By End Use

• Clinics • Hospitals • Beauty institutions

Global Obesity Treatment Market, By Region

• North America o USA o Canada • Europe o UK o France o Germany o Italy o Spain o Norway o Russia • Asia Pacific o China o India o Japan o South Korea o Australia o Malaysia o Indonesia o Vietnam • South America o Mexico o Brazil o Argentina • Middle East and Africa o GCC Countries o South Africa o Nigeria o Egypt

Key players operating in the Global Obesity Treatment Market

• Olympus Corporation • F. Hoffmann-La Roche, Ltd. • Cousin Biotech • VIVUS, Inc. • Allergan • Johnson & Johnson Services, Inc. • Arena Pharmaceuticals, Inc. • Orexigen Therapeutics, Inc. • Medtronic • USGI Medical, Inc. • Covidien plc • Mediflex Surgical Products • EnteroMedics, Inc. • Novo Nordisk A/S
Global Obesity Treatment Market 1. Preface 1.1. Report Scope and Market Segmentation 1.2. Research Highlights 1.3. Research Objectives 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations 2.3. Research Methodology 2.3.1. Secondary Research 2.3.1.1. Secondary data 2.3.1.2. Secondary Sources 2.3.2. Primary Research 2.3.2.1. Data from Primary Sources 2.3.2.2. Breakdown of Primary Sources 3. Executive Summary: Global Obesity Treatment Market Size, by Market Value (US$ Bn) 4. Market Overview 4.1. Introduction 4.2. Market Indicator 4.2.1. Drivers 4.2.2. Restraints 4.2.3. Opportunities 4.2.4. Challenges 4.3. Porter’s Analysis 4.4. Value Chain Analysis 4.5. Market Risk Analysis 4.6. SWOT Analysis 4.7. Industry Trends and Emerging Technologies 5. Supply Side and Demand Side Indicators 6. Global Obesity Treatment Market Analysis and Forecast 6.1. Obesity Treatment Market Size & Y-o-Y Growth Analysis 6.1.1. North America 6.1.2. Europe 6.1.3. Asia Pacific 6.1.4. Middle East & Africa 6.1.5. South America 7. Global Obesity Treatment Market Analysis and Forecast, By Surgery 7.1. Introduction and Definition 7.2. Key Findings 7.3. Obesity Treatment Market Value Share Analysis, By Surgery 7.4. Obesity Treatment Market Size (US$ Bn) Forecast, By Surgery 7.5. Obesity Treatment Market Analysis, By Surgery 7.6. Obesity Treatment Market Attractiveness Analysis, By Surgery 8. Global Obesity Treatment Market Analysis and Forecast, By Drugs 8.1. Introduction and Definition 8.2. Key Findings 8.3. Obesity Treatment Market Value Share Analysis, By Drugs 8.4. Obesity Treatment Market Size (US$ Bn) Forecast, By Drugs 8.5. Obesity Treatment Market Analysis, By Drugs 8.6. Obesity Treatment Market Attractiveness Analysis, By Drugs 9. Global Obesity Treatment Market Analysis and Forecast, By End Use 9.1. Introduction and Definition 9.2. Key Findings 9.3. Obesity Treatment Market Value Share Analysis, By End Use 9.4. Obesity Treatment Market Size (US$ Bn) Forecast, By End Use 9.5. Obesity Treatment Market Analysis, By End Use 9.6. Obesity Treatment Market Attractiveness Analysis, By End Use 10. Global Obesity Treatment Market Analysis, by Region 10.1. Obesity Treatment Market Value Share Analysis, by Region 10.2. Obesity Treatment Market Size (US$ Bn) Forecast, by Region 10.3. Obesity Treatment Market Attractiveness Analysis, by Region 11. North America Obesity Treatment Market Analysis 11.1. Key Findings 11.2. North America Obesity Treatment Market Overview 11.3. North America Obesity Treatment Market Value Share Analysis, By Surgery 11.4. North America Obesity Treatment Market Forecast, By Surgery 11.4.1. Adjusting gastric Banding 11.4.2. Roux-en-Y Gastric Bypass 11.4.3. Sleeve gastrectomy 11.4.4. Biliopancreatic diversion with Duodenal Switch 11.4.5. Endoscopic Procedures 11.5. North America Obesity Treatment Market Value Share Analysis, By Drugs 11.6. North America Obesity Treatment Market Forecast, By Drugs 11.6.1. Appetite suppressants 11.6.2. Combination drugs 11.6.3. Malabsorption 11.6.4. Satiety drugs 11.7. North America Obesity Treatment Market Value Share Analysis, By End Use 11.8. North America Obesity Treatment Market Forecast, By End Use 11.8.1. Clinics 11.8.2. Hospitals 11.8.3. Beauty institutions 11.9. North America Obesity Treatment Market Value Share Analysis, by Country 11.10. North America Obesity Treatment Market Forecast, by Country 11.10.1. U.S. 11.10.2. Canada 11.11. North America Obesity Treatment Market Analysis, by Country 11.12. U.S. Obesity Treatment Market Forecast, By Surgery 11.12.1. Adjusting gastric Banding 11.12.2. Roux-en-Y Gastric Bypass 11.12.3. Sleeve gastrectomy 11.12.4. Biliopancreatic diversion with Duodenal Switch 11.12.5. Endoscopic Procedures 11.13. U.S. Obesity Treatment Market Forecast, By Drugs 11.13.1. Appetite suppressants 11.13.2. Combination drugs 11.13.3. Malabsorption 11.13.4. Satiety drugs 11.14. U.S. Obesity Treatment Market Forecast, By End Use 11.14.1. Clinics 11.14.2. Hospitals 11.14.3. Beauty institutions 11.15. Canada Obesity Treatment Market Forecast, By Surgery 11.15.1. Adjusting gastric Banding 11.15.2. Roux-en-Y Gastric Bypass 11.15.3. Sleeve gastrectomy 11.15.4. Biliopancreatic diversion with Duodenal Switch 11.15.5. Endoscopic Procedures 11.16. Canada Obesity Treatment Market Forecast, By Drugs 11.16.1. Appetite suppressants 11.16.2. Combination drugs 11.16.3. Malabsorption 11.16.4. Satiety drugs 11.17. Canada Obesity Treatment Market Forecast, By End Use 11.17.1. Clinics 11.17.2. Hospitals 11.17.3. Beauty institutions 11.18. North America Obesity Treatment Market Attractiveness Analysis 11.18.1. By Surgery 11.18.2. By Drugs 11.18.3. By End Use 11.19. PEST Analysis 11.20. Key Trends 11.21. Key Developments 12. Europe Obesity Treatment Market Analysis 12.1. Key Findings 12.2. Europe Obesity Treatment Market Overview 12.3. Europe Obesity Treatment Market Value Share Analysis, By Surgery 12.4. Europe Obesity Treatment Market Forecast, By Surgery 12.4.1. Adjusting gastric Banding 12.4.2. Roux-en-Y Gastric Bypass 12.4.3. Sleeve gastrectomy 12.4.4. Biliopancreatic diversion with Duodenal Switch 12.4.5. Endoscopic Procedures 12.5. Europe Obesity Treatment Market Value Share Analysis, By Drugs 12.6. Europe Obesity Treatment Market Forecast, By Drugs 12.6.1. Appetite suppressants 12.6.2. Combination drugs 12.6.3. Malabsorption 12.6.4. Satiety drugs 12.7. Europe Obesity Treatment Market Value Share Analysis, By End Use 12.8. Europe Obesity Treatment Market Forecast, By End Use 12.8.1. Clinics 12.8.2. Hospitals 12.8.3. Beauty institutions 12.9. Europe Obesity Treatment Market Value Share Analysis, by Country 12.10. Europe Obesity Treatment Market Forecast, by Country 12.10.1. Germany 12.10.2. UK 12.10.3. France 12.10.4. Italy 12.10.5. Spain 12.10.6. Norway 12.10.7. Russia 12.11. Europe Obesity Treatment Market Analysis, by Country 12.12. Germany Obesity Treatment Market Forecast, By Surgery 12.12.1. Adjusting gastric Banding 12.12.2. Roux-en-Y Gastric Bypass 12.12.3. Sleeve gastrectomy 12.12.4. Biliopancreatic diversion with Duodenal Switch 12.12.5. Endoscopic Procedures 12.13. Germany Obesity Treatment Market Forecast, By Drugs 12.13.1. Appetite suppressants 12.13.2. Combination drugs 12.13.3. Malabsorption 12.13.4. Satiety drugs 12.14. Germany Obesity Treatment Market Forecast, By End Use 12.14.1. Clinics 12.14.2. Hospitals 12.14.3. Beauty institutions 12.15. U.K. Obesity Treatment Market Forecast, By Surgery 12.15.1. Adjusting gastric Banding 12.15.2. Roux-en-Y Gastric Bypass 12.15.3. Sleeve gastrectomy 12.15.4. Biliopancreatic diversion with Duodenal Switch 12.15.5. Endoscopic Procedures 12.15.6. Satiety drugs 12.16. U.K. Obesity Treatment Market Forecast, By Drugs 12.16.1. Appetite suppressants 12.16.2. Combination drugs 12.16.3. Malabsorption 12.16.4. Satiety drugs 12.17. U.K. Obesity Treatment Market Forecast, By End Use 12.17.1. Clinics 12.17.2. Hospitals 12.17.3. Beauty institutions 12.18. France Obesity Treatment Market Forecast, By Surgery 12.18.1. Adjusting gastric Banding 12.18.2. Roux-en-Y Gastric Bypass 12.18.3. Sleeve gastrectomy 12.18.4. Biliopancreatic diversion with Duodenal Switch 12.18.5. Endoscopic Procedures 12.19. France Obesity Treatment Market Forecast, By Drugs 12.19.1. Appetite suppressants 12.19.2. Combination drugs 12.19.3. Malabsorption 12.19.4. Satiety drugs 12.20. France Obesity Treatment Market Forecast, By End Use 12.20.1. Clinics 12.20.2. Hospitals 12.20.3. Beauty institutions 12.21. Italy Obesity Treatment Market Forecast, By Surgery 12.21.1. Adjusting gastric Banding 12.21.2. Roux-en-Y Gastric Bypass 12.21.3. Sleeve gastrectomy 12.21.4. Biliopancreatic diversion with Duodenal Switch 12.21.5. Endoscopic Procedures 12.22. Italy Obesity Treatment Market Forecast, By Drugs 12.22.1. Appetite suppressants 12.22.2. Combination drugs 12.22.3. Malabsorption 12.22.4. Satiety drugs 12.23. Italy Obesity Treatment Market Forecast, By End Use 12.23.1. Clinics 12.23.2. Hospitals 12.23.3. Beauty institutions 12.24. Spain Obesity Treatment Market Forecast, By Surgery 12.24.1. Adjusting gastric Banding 12.24.2. Roux-en-Y Gastric Bypass 12.24.3. Sleeve gastrectomy 12.24.4. Biliopancreatic diversion with Duodenal Switch 12.24.5. Endoscopic Procedures 12.25. Spain Obesity Treatment Market Forecast, By Drugs 12.25.1. Appetite suppressants 12.25.2. Combination drugs 12.25.3. Malabsorption 12.25.4. Satiety drugs 12.26. Spain Obesity Treatment Market Forecast, By End Use 12.26.1. Clinics 12.26.2. Hospitals 12.26.3. Beauty institutions 12.27. Norway Obesity Treatment Market Forecast, By Surgery 12.27.1. Adjusting gastric Banding 12.27.2. Roux-en-Y Gastric Bypass 12.27.3. Sleeve gastrectomy 12.27.4. Biliopancreatic diversion with Duodenal Switch 12.27.5. Endoscopic Procedures 12.28. Norway Obesity Treatment Market Forecast, By Drugs 12.28.1. Appetite suppressants 12.28.2. Combination drugs 12.28.3. Malabsorption 12.28.4. Satiety drugs 12.29. Norway Obesity Treatment Market Forecast, By End Use 12.29.1. Clinics 12.29.2. Hospitals 12.29.3. Beauty institutions 12.30. Russia Obesity Treatment Market Forecast, By Surgery 12.30.1. Adjusting gastric Banding 12.30.2. Roux-en-Y Gastric Bypass 12.30.3. Sleeve gastrectomy 12.30.4. Biliopancreatic diversion with Duodenal Switch 12.30.5. Endoscopic Procedures 12.31. Russia Obesity Treatment Market Forecast, By Drugs 12.31.1. Appetite suppressants 12.31.2. Combination drugs 12.31.3. Malabsorption 12.31.4. Satiety drugs 12.32. Russia Obesity Treatment Market Forecast, By End Use 12.32.1. Clinics 12.32.2. Hospitals 12.32.3. Beauty institutions 12.33. Europe Obesity Treatment Market Attractiveness Analysis 12.33.1. By Surgery 12.33.2. By Drugs 12.33.3. By End Use 12.34. PEST Analysis 12.35. Key Trends 12.36. Key Developments 13. Asia Pacific Obesity Treatment Market Analysis 13.1. Key Findings 13.2. Asia Pacific Obesity Treatment Market Overview 13.3. Asia Pacific Obesity Treatment Market Value Share Analysis, By Surgery 13.4. Asia Pacific Obesity Treatment Market Forecast, By Surgery 13.4.1. Adjusting gastric Banding 13.4.2. Roux-en-Y Gastric Bypass 13.4.3. Sleeve gastrectomy 13.4.4. Biliopancreatic diversion with Duodenal Switch 13.4.5. Endoscopic Procedures 13.5. Asia Pacific Obesity Treatment Market Value Share Analysis, By Drugs 13.6. Asia Pacific Obesity Treatment Market Forecast, By Drugs 13.6.1. Appetite suppressants 13.6.2. Combination drugs 13.6.3. Malabsorption 13.6.4. Satiety drugs 13.7. Asia Pacific Obesity Treatment Market Value Share Analysis, By End Use 13.8. Asia Pacific Obesity Treatment Market Forecast, By End Use 13.8.1. Clinics 13.8.2. Hospitals 13.8.3. Beauty institutions 13.9. Asia Pacific Obesity Treatment Market Value Share Analysis, by Country 13.10. Asia Pacific Obesity Treatment Market Forecast, by Country 13.10.1. China 13.10.2. India 13.10.3. Japan 13.10.4. South Korea 13.10.5. Australia 13.10.6. Malaysia 13.10.7. Indonesia 13.10.8. Vietnam 13.11. Asia Pacific Obesity Treatment Market Analysis, by Country 13.12. China Obesity Treatment Market Forecast, By Surgery 13.12.1. Adjusting gastric Banding 13.12.2. Roux-en-Y Gastric Bypass 13.12.3. Sleeve gastrectomy 13.12.4. Biliopancreatic diversion with Duodenal Switch 13.12.5. Endoscopic Procedures 13.13. China Obesity Treatment Market Forecast, By Drugs 13.13.1. Appetite suppressants 13.13.2. Combination drugs 13.13.3. Malabsorption 13.13.4. Satiety drugs 13.14. China Obesity Treatment Market Forecast, By End Use 13.14.1. Clinics 13.14.2. Hospitals 13.14.3. Beauty institutions 13.15. India Obesity Treatment Market Forecast, By Surgery 13.15.1. Adjusting gastric Banding 13.15.2. Roux-en-Y Gastric Bypass 13.15.3. Sleeve gastrectomy 13.15.4. Biliopancreatic diversion with Duodenal Switch 13.15.5. Endoscopic Procedures 13.16. India Obesity Treatment Market Forecast, By Drugs 13.16.1. Appetite suppressants 13.16.2. Combination drugs 13.16.3. Malabsorption 13.16.4. Satiety drugs 13.17. India Obesity Treatment Market Forecast, By End Use 13.17.1. Clinics 13.17.2. Hospitals 13.17.3. Beauty institutions 13.18. Japan Obesity Treatment Market Forecast, By Surgery 13.18.1. Adjusting gastric Banding 13.18.2. Roux-en-Y Gastric Bypass 13.18.3. Sleeve gastrectomy 13.18.4. Biliopancreatic diversion with Duodenal Switch 13.18.5. Endoscopic Procedures 13.19. Japan Obesity Treatment Market Forecast, By Drugs 13.19.1. Appetite suppressants 13.19.2. Combination drugs 13.19.3. Malabsorption 13.19.4. Satiety drugs 13.20. Japan Obesity Treatment Market Forecast, By End Use 13.20.1. Clinics 13.20.2. Hospitals 13.20.3. Beauty institutions 13.21. South Korea Obesity Treatment Market Forecast, By Surgery 13.21.1. Adjusting gastric Banding 13.21.2. Roux-en-Y Gastric Bypass 13.21.3. Sleeve gastrectomy 13.21.4. Biliopancreatic diversion with Duodenal Switch 13.21.5. Endoscopic Procedures 13.22. South Korea Obesity Treatment Market Forecast, By Drugs 13.22.1. Appetite suppressants 13.22.2. Combination drugs 13.22.3. Malabsorption 13.22.4. Satiety drugs 13.23. South Korea Obesity Treatment Market Forecast, By End Use 13.23.1. Clinics 13.23.2. Hospitals 13.23.3. Beauty institutions 13.24. Australia Obesity Treatment Market Forecast, By Surgery 13.24.1. Adjusting gastric Banding 13.24.2. Roux-en-Y Gastric Bypass 13.24.3. Sleeve gastrectomy 13.24.4. Biliopancreatic diversion with Duodenal Switch 13.24.5. Endoscopic Procedures 13.25. Australia Obesity Treatment Market Forecast, By Drugs 13.25.1. Appetite suppressants 13.25.2. Combination drugs 13.25.3. Malabsorption 13.25.4. Satiety drugs 13.26. Australia Obesity Treatment Market Forecast, By End Use 13.26.1. Clinics 13.26.2. Hospitals 13.26.3. Beauty institutions 13.27. Malaysia Obesity Treatment Market Forecast, By Surgery 13.27.1. Adjusting gastric Banding 13.27.2. Roux-en-Y Gastric Bypass 13.27.3. Sleeve gastrectomy 13.27.4. Biliopancreatic diversion with Duodenal Switch 13.27.5. Endoscopic Procedures 13.28. Malaysia Obesity Treatment Market Forecast, By Drugs 13.28.1. Appetite suppressants 13.28.2. Combination drugs 13.28.3. Malabsorption 13.28.4. Satiety drugs 13.29. Malaysia Obesity Treatment Market Forecast, By End Use 13.29.1. Clinics 13.29.2. Hospitals 13.29.3. Beauty institutions 13.30. Indonesia Obesity Treatment Market Forecast, By Surgery 13.30.1. Adjusting gastric Banding 13.30.2. Roux-en-Y Gastric Bypass 13.30.3. Sleeve gastrectomy 13.30.4. Biliopancreatic diversion with Duodenal Switch 13.30.5. Endoscopic Procedures 13.31. Indonesia Obesity Treatment Market Forecast, By Drugs 13.31.1. Appetite suppressants 13.31.2. Combination drugs 13.31.3. Malabsorption 13.31.4. Satiety drugs 13.32. Indonesia Obesity Treatment Market Forecast, By End Use 13.32.1. Clinics 13.32.2. Hospitals 13.32.3. Beauty institutions 13.33. Vietnam Obesity Treatment Market Forecast, By Surgery 13.33.1. Adjusting gastric Banding 13.33.2. Roux-en-Y Gastric Bypass 13.33.3. Sleeve gastrectomy 13.33.4. Biliopancreatic diversion with Duodenal Switch 13.33.5. Endoscopic Procedures 13.34. Vietnam Obesity Treatment Market Forecast, By Drugs 13.34.1. Appetite suppressants 13.34.2. Combination drugs 13.34.3. Malabsorption 13.34.4. Satiety drugs 13.35. Vietnam Obesity Treatment Market Forecast, By End Use 13.35.1. Clinics 13.35.2. Hospitals 13.35.3. Beauty institutions 13.36. Asia Pacific Obesity Treatment Market Attractiveness Analysis 13.36.1. By Surgery 13.36.2. By Drugs 13.36.3. By End Use 13.37. PEST Analysis 13.38. Key Trends 13.39. Key Developments 14. Middle East & Africa Obesity Treatment Market Analysis 14.1. Key Findings 14.2. Middle East & Africa Obesity Treatment Market Overview 14.3. Middle East & Africa Obesity Treatment Market Value Share Analysis, By Surgery 14.4. Middle East & Africa Obesity Treatment Market Forecast, By Surgery 14.4.1. Adjusting gastric Banding 14.4.2. Roux-en-Y Gastric Bypass 14.4.3. Sleeve gastrectomy 14.4.4. Biliopancreatic diversion with Duodenal Switch 14.4.5. Endoscopic Procedures 14.5. Middle East & Africa Obesity Treatment Market Value Share Analysis, By Drugs 14.6. Middle East & Africa Obesity Treatment Market Forecast, By Drugs 14.6.1. Appetite suppressants 14.6.2. Combination drugs 14.6.3. Malabsorption 14.6.4. Satiety drugs 14.7. Middle East & Africa Obesity Treatment Market Value Share Analysis, By End Use 14.8. Middle East & Africa Obesity Treatment Market Forecast, By End Use 14.8.1. Clinics 14.8.2. Hospitals 14.8.3. Beauty institutions 14.9. Middle East & Africa Obesity Treatment Market Value Share Analysis, by Country 14.10. Middle East & Africa Obesity Treatment Market Forecast, by Country 14.10.1. GCC Countries 14.10.2. South Africa 14.10.3. Nigeria 14.10.4. Egypt 14.11. Middle East & Africa Obesity Treatment Market Analysis, by Country 14.12. GCC Obesity Treatment Market Forecast, By Surgery 14.12.1. Adjusting gastric Banding 14.12.2. Roux-en-Y Gastric Bypass 14.12.3. Sleeve gastrectomy 14.12.4. Biliopancreatic diversion with Duodenal Switch 14.12.5. Endoscopic Procedures 14.13. GCC Obesity Treatment Market Forecast, By Drugs 14.13.1. Appetite suppressants 14.13.2. Combination drugs 14.13.3. Malabsorption 14.13.4. Satiety drugs 14.14. GCC Obesity Treatment Market Forecast, By End Use 14.14.1. Clinics 14.14.2. Hospitals 14.14.3. Beauty institutions 14.15. South Africa Obesity Treatment Market Forecast, By Surgery 14.15.1. Adjusting gastric Banding 14.15.2. Roux-en-Y Gastric Bypass 14.15.3. Sleeve gastrectomy 14.15.4. Biliopancreatic diversion with Duodenal Switch 14.15.5. Endoscopic Procedures 14.16. South Africa Obesity Treatment Market Forecast, By Drugs 14.16.1. Appetite suppressants 14.16.2. Combination drugs 14.16.3. Malabsorption 14.16.4. Satiety drugs 14.17. South Africa Obesity Treatment Market Forecast, By End Use 14.17.1. Clinics 14.17.2. Hospitals 14.17.3. Beauty institutions 14.18. Nigeria Obesity Treatment Market Forecast, By Surgery 14.18.1. Adjusting gastric Banding 14.18.2. Roux-en-Y Gastric Bypass 14.18.3. Sleeve gastrectomy 14.18.4. Biliopancreatic diversion with Duodenal Switch 14.18.5. Endoscopic Procedures 14.19. Nigeria Obesity Treatment Market Forecast, By Drugs 14.19.1. Appetite suppressants 14.19.2. Combination drugs 14.19.3. Malabsorption 14.19.4. Satiety drugs 14.20. Nigeria Obesity Treatment Market Forecast, By End Use 14.20.1. Clinics 14.20.2. Hospitals 14.20.3. Beauty institutions 14.21. Egypt Obesity Treatment Market Forecast, By Surgery 14.21.1. Adjusting gastric Banding 14.21.2. Roux-en-Y Gastric Bypass 14.21.3. Sleeve gastrectomy 14.21.4. Biliopancreatic diversion with Duodenal Switch 14.21.5. Endoscopic Procedures 14.22. Egypt Obesity Treatment Market Forecast, By Drugs 14.22.1. Appetite suppressants 14.22.2. Combination drugs 14.22.3. Malabsorption 14.22.4. Satiety drugs 14.23. Egypt Obesity Treatment Market Forecast, By End Use 14.23.1. Clinics 14.23.2. Hospitals 14.23.3. Beauty institutions 14.24. Middle East & Africa Obesity Treatment Market Attractiveness Analysis 14.24.1. By Surgery 14.24.2. By Drugs 14.24.3. By End Use 14.25. PEST Analysis 14.26. Key Trends 14.27. Key Developments 15. South America Obesity Treatment Market Analysis 15.1. Key Findings 15.2. South America Obesity Treatment Market Overview 15.3. South America Obesity Treatment Market Value Share Analysis, By Surgery 15.4. South America Obesity Treatment Market Forecast, By Surgery 15.4.1. Adjusting gastric Banding 15.4.2. Roux-en-Y Gastric Bypass 15.4.3. Sleeve gastrectomy 15.4.4. Biliopancreatic diversion with Duodenal Switch 15.4.5. Endoscopic Procedures 15.5. South America Obesity Treatment Market Value Share Analysis, By Drugs 15.6. South America Obesity Treatment Market Forecast, By Drugs 15.6.1. Appetite suppressants 15.6.2. Combination drugs 15.6.3. Malabsorption 15.6.4. Satiety drugs 15.7. South America Obesity Treatment Market Value Share Analysis, By End Use 15.8. South America Obesity Treatment Market Forecast, By End Use 15.8.1. Clinics 15.8.2. Hospitals 15.8.3. Beauty institutions 15.9. South America Obesity Treatment Market Value Share Analysis, by Country 15.10. South America Obesity Treatment Market Forecast, by Country 15.10.1. Mexico 15.10.2. Brazil 15.10.3. Argentina 15.11. South America Obesity Treatment Market Analysis, by Country 15.12. Brazil Obesity Treatment Market Forecast, By Surgery 15.12.1. Adjusting gastric Banding 15.12.2. Roux-en-Y Gastric Bypass 15.12.3. Sleeve gastrectomy 15.12.4. Biliopancreatic diversion with Duodenal Switch 15.12.5. Endoscopic Procedures 15.13. Brazil Obesity Treatment Market Forecast, By Drugs 15.13.1. Appetite suppressants 15.13.2. Combination drugs 15.13.3. Malabsorption 15.13.4. Satiety drugs 15.14. Brazil Obesity Treatment Market Forecast, By End Use 15.14.1. Clinics 15.14.2. Hospitals 15.14.3. Beauty institutions 15.15. Mexico Obesity Treatment Market Forecast, By Surgery 15.15.1. Adjusting gastric Banding 15.15.2. Roux-en-Y Gastric Bypass 15.15.3. Sleeve gastrectomy 15.15.4. Biliopancreatic diversion with Duodenal Switch 15.15.5. Endoscopic Procedures 15.16. Mexico Obesity Treatment Market Forecast, By Drugs 15.16.1. Appetite suppressants 15.16.2. Combination drugs 15.16.3. Malabsorption 15.16.4. Satiety drugs 15.17. Mexico Obesity Treatment Market Forecast, By End Use 15.17.1. Clinics 15.17.2. Hospitals 15.17.3. Beauty institutions 15.18. Argentina Obesity Treatment Market Forecast, By Surgery 15.18.1. Adjusting gastric Banding 15.18.2. Roux-en-Y Gastric Bypass 15.18.3. Sleeve gastrectomy 15.18.4. Biliopancreatic diversion with Duodenal Switch 15.18.5. Endoscopic Procedures 15.19. Argentina Obesity Treatment Market Forecast, By Drugs 15.19.1. Appetite suppressants 15.19.2. Combination drugs 15.19.3. Malabsorption 15.19.4. Satiety drugs 15.20. Argentina Obesity Treatment Market Forecast, By End Use 15.20.1. Clinics 15.20.2. Hospitals 15.20.3. Beauty institutions 15.21. South America Obesity Treatment Market Attractiveness Analysis 15.21.1. By Surgery 15.21.2. By Drugs 15.21.3. By End Use 15.22. PEST Analysis 15.23. Key Trends 15.24. Key Developments 16. Company Profiles 16.1. Market Share Analysis, by Company 16.2. Competition Matrix 16.2.1. Competitive Benchmarking of key players by price, presence, market share, Applications and R&D investment 16.2.2. New Product Launches and Product Enhancements 16.2.3. Market Consolidation 16.2.3.1. M&A by Regions, Investment and Applications 16.2.3.2. M&A Key Players, Forward Integration and Backward Integration 16.3. Company Profiles: Key Players 16.3.1. Olympus Corporation 16.3.1.1. Company Overview 16.3.1.2. Financial Overview 16.3.1.3. Product Portfolio 16.3.1.4. Business Strategy 16.3.1.5. Recent Developments 16.3.1.6. Development Footprint 16.3.2. F. Hoffmann-La Roche, Ltd. 16.3.3. Cousin Biotech 16.3.4. VIVUS, Inc. 16.3.5. Allergan 16.3.6. Johnson & Johnson Services, Inc. 16.3.7. Arena Pharmaceuticals, Inc. 16.3.8. Orexigen Therapeutics, Inc. 16.3.9. Medtronic 16.3.10. USGI Medical, Inc. 16.3.11. Covidien plc 16.3.12. Mediflex Surgical Products 16.3.13. EnteroMedics, Inc. 16.3.14. Novo Nordisk A/S 17. Primary Key Insights

About This Report

Report ID 70599
Category Healthcare
Published Date August 2020
Updated Date
Contact Us